Class Action vs Individual Lawsuit for a Dangerous Product

Personal injury attorneys ask one question before anything else when a defective product client walks in: how bad was the injury? The answer shapes everything that follows, including whether a class action is even on the table.

The choice between joining a class action lawsuit and filing your own product liability claim isn't a procedural formality. It determines your compensation ceiling, your timeline, your control over the case, and whether your specific medical history matters at all. Most people assume class action is the safer, easier option. For plaintiffs with serious, individualized injuries, that assumption is a pain.

The tension here is real: class actions exist precisely because individual claims against large corporations are expensive and risky to bring alone, yet the very structure that makes them viable for small-damage plaintiffs systematically underpays those with the most serious harm. How you resolve that tension depends on variables your attorney will assess before you decide anything, and the most important variable is one most people don't think to ask about.

A class action consolidates thousands of similar claims into one proceeding, which is structurally efficient and personally costly to any plaintiff whose injuries deviate significantly from the class norm. The settlement or verdict produces a common fund, then divides it among class members according to a distribution formula. That formula is built on a representative plaintiff's injuries, not yours.

Here's the mechanism: the named class representative's experience becomes the evidentiary center of the case. If the representative suffered moderate economic loss and minor physical symptoms, the valuation model reflects that. A class member who developed a permanent condition from the same product gets slotted into a distribution tier that doesn't account for her actual medical trajectory. She may receive $800 when her out-of-pocket costs alone were $40,000. She also, in most cases, waives the right to file individually once she accepts the class settlement.

Or rather: it's not just that she gets less. She gets locked out of getting more. Opting out of a class before the settlement is finalized is the only path to preserving individual rights, and that window closes. Missing the opt-out deadline is one of the more irreversible mistakes in consumer litigation.

The Federal Rules of Civil Procedure, specifically Rule 23, govern class certification in federal court. For a class to be certified, the court must find numerosity (enough similar claimants), commonality (shared legal questions), typicality (the representative's claims are typical), and adequacy (the representative and counsel will fairly represent the class). These requirements were designed to protect class members. In practice, they also define who the case is really built around, and it is not the outlier with catastrophic injuries.

File individually when your damages are large enough to justify the cost of litigation, when your injuries are medically distinct from the typical claimant, or when the facts of your exposure differ materially from others in any potential class. These aren't abstract criteria. A common practical guideline among product liability attorneys is that individual litigation makes economic sense when provable damages (medical expenses, lost wages, future care costs) exceed roughly $100,000, though that threshold is a heuristic, not a published rule, and varies by jurisdiction and attorney.

What changes in an individual case is that your specific evidence goes to the center. Your medical records, your treating physicians, your documented economic losses, your pain and suffering history become the evidentiary core rather than supporting noise. The defendant cannot reduce your claim to a distribution formula built on someone else's experience.

Individual product liability claims in the US typically proceed on one of three theories: manufacturing defect (this specific unit was made incorrectly), design defect (the entire product line was unreasonably dangerous), or failure to warn (the manufacturer didn't adequately communicate a known risk). In practice, plaintiffs with serious injuries often plead all three and let discovery narrow the viable theory. The strongest cases tend to anchor on design defect or failure to warn because they implicate the entire product line, which raises the defendant's exposure and changes settlement dynamics.

The downside is real. Individual litigation is expensive, can take three to five years through trial, and carries the risk of a defense verdict that leaves you with nothing but legal fees. Class actions, for all their limitations, provide a near-certain (if modest) recovery. For a plaintiff with $15,000 in documented losses and a common injury pattern, the math genuinely favors the class.

The alternative most injury attorneys actually push clients toward, when individual damages are substantial but the defendant is a large manufacturer with many similar claimants, is a mass tort. This is the realistic competitor to both class action and standalone individual litigation, and it's the option most general searches on this topic don't adequately explain.

In a mass tort, claims are coordinated, often through a federal multidistrict litigation (MDL) procedure under 28 U.S.C. § 1407, but each plaintiff retains an individual case. Your damages aren't averaged into a distribution formula. Your medical records matter. Your specific causation argument matters. The coordination exists to share discovery costs, consolidate pretrial motions, and create negotiating leverage through sheer volume. The individual cases are then typically resolved through a negotiated settlement matrix that still accounts for injury severity tiers.

Mass torts have produced some of the largest per-plaintiff recoveries in product liability history, including litigation involving pharmaceutical products, implantable medical devices, and consumer goods with documented toxic exposures. The MDL structure is what made those recoveries possible at scale. What you'll notice when comparing mass tort settlement outcomes to class action distributions is that the injury-severity differential in payouts is far larger in mass torts, which is the point.

The practical checklist before choosing between these three paths: check whether an MDL already exists for your product, verify the opt-out deadline for any pending class action, confirm your documented damages figure with your attorney, and assess how medically distinct your injuries are from published reports of typical claimant injuries. Those four inputs determine your realistic options before legal strategy enters the conversation.

That framing misses something. Clients often frame this as a question about legal structure when it's really a question about evidence. The path that wins is the one that puts your specific evidence at the center. Class action puts the representative's evidence at the center. Individual litigation puts yours there exclusively. Mass tort MDL puts yours there alongside thousands of others, with coordination benefits. The evidence question should drive the structure choice, not the other way around.

There are categories of cases where class action is not just the practical default but the correct answer. If your individual damages are modest (under roughly $10,000 to $20,000, as a rough guideline), pursuing individual litigation almost certainly costs more than it recovers, after attorney fees and litigation expenses. Class action exists, in large part, to make corporations liable for widespread low-severity harm that would otherwise go uncompensated because no individual claimant has enough at stake to fight.

Economic harm cases are the clearest fit: a defective product that was overpriced due to undisclosed defects, a consumer electronics product that caused documented property damage but no physical injury, a product that required systematic replacement costs. These cases have relatively uniform damages across the class, which is exactly what the class action distribution model handles well.

The consumer protection class actions brought under state consumer fraud statutes, which most states have, are frequently more powerful than federal product liability theories for economic harm cases. State AG offices track active class certifications, and the consumer protection bar is well-developed in states like California (under the Consumer Legal Remedies Act and UCL), Illinois, and New Jersey. Knowing which state's law governs your purchase matters here.

If you ignore this decision entirely and simply wait, the statute of limitations will close most product liability claims. Under most state laws, the limitations period runs from the date of injury or the date you discovered (or reasonably should have discovered) the injury, typically two to four years depending on state law and theory. Waiting until you've read enough news coverage about a product to feel certain is not a legal strategy. By then, you may have missed both the opt-out window for a class and the individual filing deadline.

I'd start with a single consultation from a plaintiff-side product liability attorney before deciding anything. Not a general personal injury attorney. Product liability is a subspecialty, and the attorney's familiarity with MDL dockets, class certification requirements, and state consumer protection theories will determine whether you get an accurate picture of your options or a generic one.

The American Association for Justice (AAJ) maintains a referral directory, and most plaintiff-side product liability attorneys handle these consultations on a contingency basis, meaning you don't pay unless you recover. State bar association referral services are a secondary option, though the quality varies more. What you're assessing in that first consultation isn't just whether you have a case. You're assessing whether the attorney knows the specific product category, whether there's active litigation (class, MDL, or otherwise) involving the same defendant, and what your likely damages range looks like under honest valuation.

Before that consultation, gather: the product itself or its model and lot number, proof of purchase, all medical records documenting the injury and its treatment, a documented record of economic losses (pay stubs, invoices, out-of-pocket receipts), and any communications with the manufacturer about the defect or injury. Walk in with that file and the attorney can give you a real assessment. Walk in empty-handed and you'll get generalities.

One thing this article won't address: claims against retailers rather than manufacturers, which involves a different liability chain and different insurance dynamics. That's a separate analysis, and conflating it with manufacturer liability is a mistake that leads to the wrong defendant and a weaker case.

The structure of your claim should follow your evidence, not the other way around. Here's how to think about it concretely.

If your documented damages are under $20,000 and your injuries match the typical pattern for your product's known issues, joining the class (or waiting to see if one certifies) is usually rational. The individual litigation math doesn't work in your favor, and a class or MDL settlement provides real recovery without the risk of a defense verdict.

If your documented damages exceed $100,000 or your medical situation is materially more severe than the typical claimant's, opting out of any class and pursuing individual or MDL participation is almost always correct. You are systematically underpaid by class distribution formulas, and your evidence justifies the cost of a more individualized path.

If your damages fall in the middle, or if you're uncertain about injury severity, the MDL path is often the right answer: individual preservation of your claim combined with the cost and leverage benefits of coordination. An experienced product liability attorney can tell you within the first consultation whether an MDL exists or is likely to form for your product category.

The class action vs. individual lawsuit framing, as commonly presented, is actually a false binary. The real question is: what legal structure puts your specific injuries at the center of the valuation? Answer that, and the path becomes clearer.

If you've been injured by a defective product, consult a plaintiff-side product liability attorney before the statute of limitations closes. Most states give you two to four years from the date of injury or discovery of injury, and that clock doesn't pause while you research.

Find out immediately whether a class action or MDL is active for your product. If a class exists, locate the opt-out deadline. Missing that deadline forfeits your right to pursue individual or MDL recovery, full stop.

Document everything now: medical records, economic losses, proof of purchase, the product itself. That file is the difference between a real consultation and a speculative one. Your attorney cannot accurately assess your options without it, and accurate assessment of your damages is the single factor that determines whether class action, individual litigation, or mass tort MDL is the right answer for your situation.